Mali Suzuki

Mali Suzuki, CCRA, currently serves as Clinical Project Manager and Study Lead at Recursion since February 2023, overseeing global trials in rare diseases and oncology. Prior experience includes a role as Clinical Trial Manager at Ultragenyx from January 2020 to January 2023, where responsibilities encompassed study start-up and maintenance for 26 sites, recruitment strategies for Phase 2/3 studies, and significant contributions to protocol amendments and unblinding processes. Earlier positions include Senior Clinical Trial Specialist and In-House CRA at Xencor, where Mali managed site activations and vendor relationships for oncology studies, as well as a Clinical Trials Assistant at IQVIA, managing regulatory documentation for various sites. With a foundational education in Biopsychology from UC Santa Barbara, Mali has been recognized with the UltraRare Award for outstanding contributions in the field.